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Abstract
Background: Adolescents and young adult (AYA) cancer survivors may have unique physical, psychological and
social needs due to their cancer occurring at a critical phase of development. The aim of this study was to develop
a psychometrically rigorous measure of unmet need to capture the specific needs of this group.
Methods: Items were developed following a comprehensive literature review, focus groups with AYAs, and
feedback from health care providers, researchers and other professionals. The measure was pilot tested with 32
AYA cancer survivors recruited through a state-based cancer registry to establish face and content validity. A main
sample of 139 AYA cancer patients and survivors were recruited through seven treatment centres and invited to
complete the questionnaire. To establish test-retest reliability, a sub-sample of 34 participants completed the
measure a second time. Exploratory factor analysis was performed and the measure was assessed for internal
consistency, discriminative validity, potential responsiveness and acceptability.
Results: The Cancer Needs Questionnaire - Young People (CNQ-YP) has established face and content validity, and
acceptability. The final measure has 70 items and six factors: Treatment Environment and Care (33 items); Feelings
and Relationships (14 items); Daily Life (12 items); Information and Activities (5 items); Education (3 items); and
Work (3 items). All domains achieved Cronbach’s alpha values greater than 0.80. Item-to-item test-retest reliability
was also high, with all but four items reaching weighted kappa values above 0.60.
Conclusions: The CNQ-YP is the first multi-dimensional measure of unmet need which has been developed
specifically for AYA cancer patients and survivors. The measure displays a strong factor structure, and excellent
internal consistency and test-retest reliability. However, the small sample size has implications for the reliability of
the statistical analyses undertaken, particularly the exploratory factor analysis. Future studies with a larger sample
are recommended to confirm the factor structure of the measure. Longitudinal studies to establish responsiveness
and predictive validity should also be undertaken.
Keywords: Adolescents and young adults, cancer, unmet needs, measure development, psychometric evaluation,
reliability, validity
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Cancer in adolescents and young adults (AYAs) com-
prises approximately 0.5-2% of all cancer diagnoses
[1-4]. While definitions of adolescence and young adult-
hood vary, AYAs are commonly defined as those aged
15 to 30 years [2,5,6]. Five year survival among AYAs
varies depending on the type of cancer diagnosed, how-
ever, overall survival rates range between 73% and 83%
[1,4,7]. Treatments may be lengthy and have been asso-
ciated with both short-term side effects, including nau-
sea (more than 35%)[8] and fatigue (30-93%)[9], and
long-term consequences, such as infertility, secondary
primary malignancies and cardiotoxicity [5].
Adolescence and young adulthood is a critical phase
of physical, emotional, cognitive and social development
[10,11]. As such, a cancer diagnosis may have profound
effects on the lives of AYAs, interfering with the attain-
ment of normal developmental milestones [11-13].
Increased dependence on family members at a time
when AYAs would normally be developing their own
independence may lead to changes in parent-child
dynamics and conflict within the family [11]. Interrup-
tions to schooling may result in subsequent difficulties
with employment or educational achievements [5]. Body
image concerns, difficulty accessing sexual health knowl-
edge and obstacles to developing close interpersonal
relationships may also serve as barriers for developing
sexual identity in this group [12].
A first step in improving psychosocial outcomes for
AYA cancer survivors is to accurately identify and prior-
itise their psychosocial needs [14,15]. A recent review of
multi-dimensional measures of psychosocial health for
AYA cancer survivors found two critical limitations.
First, although most studies examined face and con-
struct validity, few examined test-retest reliability or dis-
criminative validity [16]. Second, there was an absence
of validated unmet needs assessments, with most avail-
able measures focussing on quality of life [16]. Measures
of unmet need are important as they provide direct
information on consumer preferences that can be used
to develop optimally relevant and cost-effective services
[17].
Despite the lack of psychometrically rigorous unmet
needs scales available for AYAs with cancer, recent stu-
dies in the United States have indicated that the number
of unmet needs reported by this population group may
be high [18]. As a consequence, there is a need to
develop a scale to assess the unmet needs of AYAs
which is relevant to both young people undergoing can-
cer treatment, as well as to those in the post-treatment
survivorship phase.
The aim of this study was to establish the psycho-
metric properties of the Cancer Needs Questionnaire
-Young People (CNQ-YP), a measure designed to cap-
ture the perceived needs of AYA cancer patients and
survivors. Specifically, the aims were to: 1) establish face
and content validity; and 2) perform exploratory factor
analysis, assess internal consistency, and examine the
test-retest reliability, discriminative validity, responsive-
ness and acceptability of the measure.
Methods
Establish face and content validity
A number of steps were undertaken to develop the mea-
sure upon which psychometric evaluation was con-
ducted. These are described below:
Literature review to identify items, domains and response
scale
Medline, PsycINFO, Embase and CINAHL databases
were searched to identify existing scales developed to
assess the unmet needs of cancer patients or survivors
of any age. The following keyword combinations: [neo-
plasm or cancer or oncol*] and [perceived need* or
unmet need*] and [questionnaire or survey or measure
or scale] were used in the database search. Publications
reporting the development or psychometric properties
of unmet needs measures were retained, and measures
were examined to identify items and domains relevant
to AYA cancer survivors.
The literature review identified 108 items, organised
into seven domains, which were conceptually relevant to
AYAs experiences of cancer. Relevant items were modi-
fied to reflect current life events among AYAs such as
studying, early employment and supporting young
families. Item readability was adapted to reflect the
appropriate reading level of AYAs. An overall grade 6
reading level (confirmed by the Flesch-Kincaid Grade
Level in Microsoft Word) was chosen because young
people undergoing treatment for cancer may have
missed substantial proportions of their schooling
[11,19]. The response scale for the measure was adapted
from the Cancer Needs Questionnaire (CNQ) and Sup-
portive Care Needs Survey (SCNS). This response for-
mat has been rated as easy to follow and use by adult
cancer populations [17,20,21].
Focus group with AYA cancer survivors
Adolescents and young adults with cancer were
recruited through CanTeen Australia. CanTeen is the
peak support organisation in Australia for AYAs aged
12-24 years affected by cancer. Six AYAs aged 14-19
years participated in the focus group. Using the draft
questionnaire derived from the literature, participants
w e r ea s k e dt ol i s ti s s u e so rn e e d sw h i c hw e r em o s t
i m p o r t a n to rd i f f i c u l tf o rt h e ma n dt op r o v i d eo t h e r
comments regarding item content, wording of questions
and ease of completion.
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general public
Health professionals from a regional hospital in New
South Wales (NSW) Australia were nominated and
invited by a paediatric oncologist to join a panel to
review the draft needs instrument. Twelve health profes-
sionals participated in the panel which included one
paediatric oncologist, two paediatric haematologists,
three oncology nurses, one cancer care coordinator, one
social worker, one psychologist, one oncology pharma-
cist, one physiotherapist and one occupational therapist.
All health professionals had experience working directly
with AYA cancer populations. The panel were asked to
provide feedback on the content of the survey and sug-
gest additional items.
Eight researchers from Australia and Canada with
expertise in the development of unmet needs measures
for cancer populations were asked to provide critical
feedback on the domains, items and response scale of
the measure via email. A convenience sample of twelve
individuals from the general population, who were
known to the research team and were not from a medi-
cal or research background, were also asked to provide
feedback on the questionnaire in terms of its language
and clarity. This sample included adult professionals,
such as school teachers and engineers, as well as parents
and AYAs who had not experienced cancer.
Revision of measure
Feedback and advice received from all participants led to
a revised response scale and stem for the measure, and
one extra domain (total of eight domains). The initial
number of items was also modified. Four items were
removed, and 31 items added taking the total number of
items from 108 to 139.
Pilot testing
The measure was pilot tested with AYAs recruited from
a population-based cancer registry in Australia. Adoles-
cents and young adults who participated in the pilot
were: 1) aged 14 to 19 years at diagnosis; and 2) had
been diagnosed with cancer in the last five years
(between January 1 2002 and December 31 2007). The
upper age limit of 19 years at diagnosis was selected, as
the World Health Organisation (WHO) defines adoles-
cents as being between 10-19 years of age [22]. The
lower limit was chosen because, in Australia, AYAs aged
14 years and older have the legal right to make their
own decisions about the type of health care they receive
[23]. The eligibility criteria of 5 years since diagnosis
e n s u r e dt h a tt h es a m p l ec o m p r i s e do fy o u n gp e o p l eu p
to the age of 24 years. Details of the pilot study are pre-
sented elsewhere [24].
Of the 32 AYAs who participated in the pilot test,
53% were female and 90% had completed treatment. A
quarter of participants (25%, n = 8) commented that
they found the response time-frame, “in the past
month”, did not allow them to express all the concerns
about unmet needs they had experienced throughout
their cancer journey, especially during treatment. There-
fore, the time-frame of the response scale was modified
to “any time since your cancer diagnosis” for five
domains (Cancer Treatment Staff, Cancer Treatment
Centre, Education, Work and Information). For the
remaining three domains (Feelings, Relationships and
Daily Life), the response time-frame remained “in the
last month”.
Establish psychometric properties
Description of the Cancer Needs Questionnaire - Young
People (CNQ-YP)
Face and content validity was established using the pro-
cedures above. The resulting measure had 139 items
presented in eight domains: 1) Cancer Treatment Staff
(36 items); 2) Cancer Treatment Centre (11 items); 3)
Education (10 items); 4) Work (10 items); 5) Informa-
tion (9 items); 6) Feelings (35 items); 7) Relationships
(18 items); and 8) Daily Life (10 items). Items were
r a t e du s i n gaf i v e - p o i n tr e s p o n s es c a l ef r o m“No Need”
to “Very High Need”.
Items in the Education, Work and Relationships
domain were only answered if they were relevant to the
AYA’s situation. Two screening questions determined
whether the young person was currently studying, two
screening questions determined whether the young per-
son was currently employed, and one screening question
determined if the AYA had a “spouse/partner or boy-
friend/girlfriend” or “sibling/s or step-brothers/sisters”.
Participants
Adolescents and young adults were eligible to partici-
pate in the main trial if they: 1) had received treatment
for cancer at one of seven identified treatment centres
in Australia; 2) had been diagnosed with an invasive
cancer in the last five years (between 1 January 2004
and 31 December 2009); 3) were aged 14 to 25 years
inclusive at the time of diagnosis (e.g. currently up to 30
years of age); and 4) had not participated in the pilot
study. Participants were also confirmed by their treating
clinician as: 5) having a lifee x p e c t a n c yo fa tl e a s t1 2
months; 6) being physically and mentally able to com-
plete a survey; and 7) being sufficiently literate in Eng-
lish to complete the measure.
Procedure
Relevant institutional ethics approvals were obtained for
the study. Recruitment commenced in August 2009 and
data collection was completed in May 2010. Adolescents
and young adults who met the eligibility criteria were
identified from medical records at each treatment cen-
tre. The principal clinician at each treatment centre
mailed a study information pack to eligible AYAs and
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research team. Those who agreed were mailed a survey
packet containing a reply paid envelope, a copy of the
CNQ-YP, and questions about demographic characteris-
tics including: marital status; language preferences; living
arrangements; education; preferences regarding the sur-
vey format and locations for survey completion; and
feedback of results to health professionals, treatment
centres, researchers and other organisations. Reminder
letters were sent to non-responders at two weeks and a
reminder phone call was made at four weeks following
the initial mailout.
Return of the completed measure was taken as a parti-
cipant’s consent for their data to be included in the
study. In order to evaluate the test-retest reliability of
the measure, all participants who agreed to be contacted
again were sent copies of the CNQ-YP one week follow-
ing receipt of their initial survey and asked to complete
the measure a second time. The one-week time-frame
was chosen to minimise the chance that patients had
substantial changes in their unmet needs or could recall
their previous responses [25].
Statistical analysis
The demographic characteristics of AYAs were reported
using descriptive statistics (frequencies, proportions,
means, medians and 95% confidence intervals). Differ-
ences in the characteristics of consenters and non-con-
senters were examined using the Chi-square statistic.
Psychometric evaluation
Factor analysis
Items which had greater than 90% of respondents indi-
cating the same level of need and items answered by ≤
10% of respondents were excluded from the measure.
Observations with a missing value for any of the
included items were excluded from the factor analysis
using list-wise deletion. Exploratory factor analysis using
the principal components method (PCA) and Eigenvalue
> 1 rule was performed. Factors were orthogonally
rotated using the varimax procedure and factors which
accounted for greater than 5% of the variance were con-
sidered important. Items which had a factor loading of
> 0.40 on only one factor, or where > 20% of partici-
pants indicated having a high or very high need for the
item, were kept [26]. Spearman’s rank correlation coeffi-
cient was then used to identify items which were highly
correlated with each other (correlations > 0.90) and had
< 20% of participants indicating a high or very high
need, which could be further excluded from the factors.
Internal consistency
Items which had an item-total correlation with the total
scale of < 0.20 were discarded from the measure. For
each factor, a Cronbach’s coefficient alpha (a) value of >
0.70 and < 0.95 was considered acceptable.
Test-retest reliability
Aw e i g h t e dC o h e n ’s kappa coefficient (), was used to
measure the level of agreement between responses at
baseline (time 1) and retest (time 2). Items which had a
weighted kappa of > 0.60 were considered to have excel-
lent test-retest reliability and were retained. To ensure
items related to high unmet needs were not dismissed,
items which did not obtain a weighted kappa of > 0.60
but for which > 20% of participants indicated having a
high or very high need, were also kept.
Discriminative validity
In order to compare different groups of participants,
factor scores were calculated by summing all raw scores
for items within the factor and dividing by the number
of non-missing items. As all items in the measure were
worded and scored in the same positive direction, no
reversing of response scores for items was required.
Observations with missing values for > 50% of items
within a factor were excluded from the analysis.
Based on previous research [27-30], it was hypothe-
sised that young people receiving treatment would have
a higher median factor score for all factors, compared
with young people who had finished treatment. A non-
parametric Wilcoxon rank-sum test was computed to
determine if any significant differences between the fac-
tor scores of these two groups existed.
Responsiveness
Responsiveness was gauged using floor and ceiling
effects. Factors where less than 5% of participants scored
the lowest possible score or the highest possible score
were considered acceptable.
Acceptability
Acceptability of the measure was assessed using the fol-
lowing four questions: 1) “I found the instructions easy
to follow"; 2) “I found the questions clear"; 3) “If o u n d
the answer choices easy to understand"; and 4) “If o u n d
the questions distressing”. Items were scored on a five
point Likert scale from “Strongly Disagree” to “Strongly
Agree”. The acceptability of the measure was reported
using frequencies, proportions, and 95% confidence
intervals.
Results
Participants, response rates and consent bias
Five hundred and seventy-seven eligible AYAs were
identified by their clinicians’ at the treatment centres,
and 280 of these (49%) consented to be contacted by
the research team. Of the 280 young people contacted,
139 (50%) returned a questionnaire. Of the 139 partici-
pants who completed the measure at baseline (time 1),
101 (73%) consented to be contacted a second time and
were sent a retest survey, with 34 (34%) completing the
measure at time 2. The time between being sent and
returning the retest measure ranged between 9 and 64
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days).
The demographic characteristics of AYAs who con-
sented to participate in the baseline study, and those
AYAs who did not consent, can be seen in Table 1.
Consenters were significantly younger than non-consen-
ters, and females were over-represented in the consent-
ing sample. There were no significant differences
between the demographic characteristics of AYAs who
completed both the baseline and retest surveys, com-
pared to AYAs who completed the baseline survey only.
Psychometric evaluation
Factor analysis
No items had > 90% of participants reporting the same
level of need, indicating reasonable variability of
responses within items. Only two items in the measure
had missing values greater than 10% (items 126 and 128
from the Relationships domain). These two items were
removed from the measure, leaving 137 items prior to
conducting factor analysis.
Of the 139 participants who completed the measure,
111 observations had no missing values for any items
and were included in the analysis. Due to the screening
questions, only a subset of AYAs completed the
domains related to Education and Work, meaning there
were different numbers of observations relating to dif-
ferent participants. Therefore, the initial factor analysis
was undertaken without these two domains. Following
the initial factor analysis, the Work and Education
domains were added to the analysis, one at a time.
Initial factor analysis of the six main domains (112 of
137 items) revealed 18 factors with Eigenvalues > 1.
When the factors were orthogonally rotated, three fac-
tors accounted for greater than 5% of the variance. A
three-factor forced analysis and rotation confirmed that
the three-factor structure was the simplest and clearest.
Ninety-five items fell into these three factors and
accounted for 58% of the total variance, 17 items were
removed. When the 20 items from the Education and
Work domains were independently added to the factor
analysis, two additional factors were identified and 10
items were removed, taking the total number of factors
to five. Five additional items from the Relationships sub-
domains (Partners and Siblings) had significant loadings
> 0.40 on a single factor and all were added to Factor 2.
An item-item Spearman correlation matrix for each of
the five factors and 108 items revealed that two items
from Factor 2 had correlations > 0.90. However, these
items appeared to capture different aspects of the
patient/staff relationship; therefore, neither item was
removed from the measure.
Internal consistency
Item-total correlations for items within all five factors
were > 0.20 and ranged from 0.33 to 0.88. All factors
had Cronbach’s alphas of > 0.70, indicating good inter-
nal consistency.
Test-retest reliability
Although traditionally performed prior to factor analysis,
test-retest reliability was performed after factor analysis
in the present study due to the small sample size (n =
34). This allowed the number of items included in the
test-retest analysis to be reduced, thereby limiting the
likelihood of type 1 error. Weighted kappa values
between responses at time 1 and time 2 ranged from
0.09 to 0.94. Twenty-four items had a weighted kappa of
< 0.60 and < 20% of participants indicating a high or
very high need, and were therefore excluded from the
measure leaving 84 items.
Revised factor analysis and internal consistency
Following test-retest reliability analysis, factor analysis
was repeated to confirm the factor structure of the mea-
sure. One hundred and sixteen observations had no
missing values for any items and were included in the
analysis. The number of important factors increased
from five to six. The four main factors explained 63% of
the variance. Fourteen items did not have unique factor
loadings > 0.40 and were removed from the measure,
leaving 70 items. All but six items loaded on the same
factor as in the previous factor analysis, with five of
these loading on the new factor. The items and factor
loadings corresponding to these six factors are presented
in Table 2.
Internal consistency of the measure was re-calculated
on the shortened measure. Item-total correlations of the
70 items for all six factors were still > 0.20 and ranged
from 0.32 to 0.90. All factors maintained alphas > 0.70
(Table 3).
Discriminative validity
Of the 139 AYAs who completed the measure, six parti-
cipants were unsure of their treatment status and were
excluded from the known-groups comparison. Partici-
pants receiving treatment had higher median factor
scores than those who had finished treatment for all
Table 1 Demographic characteristics of consenters and









n (%) n (%) c
2 df p
Female 188 (43) 89 (64) 18.8 1 <
0.01
Non-haematological 243 (56) 73 (53) 0.31 1 0.58






Age at diagnosis 22 (19-24) 21 (18-23) 2.24 0.03
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Factor 1 - Treatment Environment and Care (n = 116)
Cancer treatment staff telling
me:
1 about my diagnosis 0.76
2 what might happen during treatment 0.77
4 whether I had the option to decline treatment 0.54
5 about the short-term side-effects of treatment 0.73
6 about the long-term side-effects of treatment 0.65
7 my chances of a full recovery 0.78
8 what would happen when treatment finished 0.71
9 whether I would be able to have children 0.60
12 whether my treatment was working 0.87
13 my test results as soon as possible 0.87
14 the way I felt was normal 0.80
15 how to manage my medication 0.82
16 what I could do to stay healthy 0.67
17 what to do if I noticed a particular side-effect 0.74
Having cancer treatment staff
who:
20 listened to my concerns 0.89
21 treated me as an individual 0.87
22 were respectful 0.93
23 were approachable 0.91
24 were friendly 0.91
25 could have a laugh with me 0.90
26 explained what they were doing 0.89
27 spoke to me in a way that I could understand 0.90
28 let me talk about my feelings 0.77
29 let me ask questions 0.90
30 let me make decisions about my treatment 0.74
31 talked to me in private, without my family 0.66
Being able to have: 39 time to myself 0.55
41 privacy 0.51
42 pleasant surroundings 0.52
43 good food 0.45
46 a choice of cancer specialists 0.64
47 the same cancer staff throughout treatment 0.63
48 a choice of times for appointments 0.64
Factor 2 - Daily Life (n = 116)
Being able to: 110 make plans or think about the future 0.51
Coping with: 102 changes in my physical ability 0.68
103 changes in my appearance 0.69
107 not being able to do the same things as other people
my age
0.75
117 my parent/s being over-protective 0.49
Managing: 134 pain 0.65
135 medication 0.48
136 physical side-effects of treatment 0.76
137 feeling tired 0.72
138 loss of mobility 0.65
142 to take part in social activities 0.71
143 to travel to social events 0.67
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however these differences were not statistically signifi-
cant (see Table 4).
Potential responsiveness
The proportion of participants who scored the mini-
mum and maximum scores for each factor can be seen
in Table 5. The proportion of participants ranged from
0% to 5.1% for the maximum score to 8.3% to 43% for
the minimum score, with large proportions of partici-
pants having floor effects in the “Education” and
“Work” factors (42% and 43% respectively).
Acceptability
When asked about the acceptability of the measure, 80%
of participants agreed that the instructions were easy to
follow (n = 111, CI 72-86%), 73% agreed that the ques-
tions were clear (n = 102, CI 65-80%) and 56% (n = 78,
CI 48-64%) agreed that the answer choices were easy to
understand. Seventy-eight percent (n = 108, CI 71-84%)
of AYAs disagreed that the questions were distressing.
Discussion
This research attempted to establish the face and con-
tent validity, factor structure, internal consistency, test-
retest reliability, discriminative validity, potential respon-
siveness and acceptability of the CNQ-YP using rigorous
psychometric criteria. Factor analysis and the assessment
of test-retest reliability resulted in a final measure with
six factors and 70 items (75 items including the five
screening items): 1) Treatment Environment and Care
(33 items); 2) Daily Life (12 items); 3) Feelings and Rela-
tionships (15 items including 1 screening item); 4) Infor-
mation and Activities (5 items); 5) Education (5 items
Table 2 Factor structure of the CNQ-YP from the revised factor analysis (Continued)
Factor 3 - Feelings and Relationships (n = 116)
Feeling: 84 frustrated 0.56
86 anxious or nervous 0.73
Worrying about: 91 my cancer spreading 0.76
92 my cancer returning 0.66
93 whether my cancer treatment has worked 0.68
95 having cancer treatment 0.70
97 how my family is coping 0.68
Finding: 98 inner strength 0.66
Being able to: 112 accept my diagnosis 0.60
113 be independent 0.51
Coping with: 125 changes in my relationship with my partner 0.53*
131 changes in my relationships with my sibling/s 0.59*
Knowing how to: 132 ask my sibling/s for support 0.51*
133 give support to my sibling/s 0.52*
Factor 4 - Information and Activities (n = 116)
Being able to: 37 spend time with people my own age 0.44
38 talk to people my age who had been through a similar
experience
0.69
Being able to have: 44 leisure spaces and activities 0.45
Finding information that: 75 was specifically designed for me 0.61
81 described relaxation techniques 0.54
Factor 5 - Education (n = 65)
Being able to: 56 attend classes 0.69
58 get extensions or special consideration 0.74
59 get guidance about study options or future career
paths
0.56
Factor 6 - Work (n = 90)
Knowing: 71 how much work I would miss 0.67
72 how to ask managers/co-workers for support 0.78
74 that managers/co-workers had support to help them
cope
0.76
% of Total Variance 31% 13% 11% 8% n/a n/a
*AYAs only completed these items if relevant to their situation. Item 125 was completed by n = 54 participants, Items 131, 132 and 133 were completed by n =
96 participants. These items do not form part of the total variance explained.
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including 2 screening items).
There are a number of limitations related to the study
sample and methodology which should be considered
when interpreting these results.
Limitations
The primary limitation of the research was the size of
the sample achieved. Only 139 AYAs recruited through
the seven treatment centres completed and returned the
measure (an overall response rate of 50%). Other studies
describing the development of measures for AYA cancer
patients have reported response rates of around 90%
[28,30,31]. However, the age range of these samples (8-
20 years) was lower than in the current study (16-30
years). One study describing the development of a mea-
sure for a similar age group (16-28 years) only achieved
a response rate of 53% [32]. Reasons for lower response
rates with older AYA samples, compared with younger
samples, are speculative. AYAs in this age group are
highly mobile [7,33]. Therefore, it is possible that a large
proportion of AYAs may not have received the ques-
tionnaire because of incorrect contact details. It is also
possible that some young people were not interested in
participating in this type of research or perceived that
the research was not relevant to their current circum-
stances. Low participation may be especially applicable
to psychosocial research studies where personal issues
such as feelings and emotions related to cancer are dis-
cussed. Similar results have been found with adult breast
cancer survivors [34], indicating that participants in psy-
chosocial cancer research may be self-selected and are
only representative of a sub-population of survivors who
wish to talk about their experiences.
The small sample size has implications for the statisti-
cal analyses undertaken, particularly the exploratory fac-
tor analysis. When performing factor analysis it is
recommended that the number of participants in the
sample be at least five times the number of items in the
measure [35]. As there were 139 items in the original
measure, only a 1:1 item-to-participant ratio was actu-
ally achieved. This may have meant that some important
items reported as high or very high unmet needs by
smaller sub-samples of participants did not achieve high
correlations with other items or factors in the measure
[36]. However, as the inclusion criteria allowed items
which had greater than 20% of participants reporting a
high or very high level of need to be retained, it is unli-
kely that items considered important by sub-samples of
AYAs were excluded.
The sample for the test-retest analysis was also small
and the median time to return the retest measure was
greater than the recommended 2-14 days [37]. Conse-
quently, responses to the retest measure may have
reflected a change in participants’ needs [37]. Despite
the longer than recommended retest period, the major-
ity of items had acceptable kappa values (> 0.60), and as
the time-frame for the response scale was either “any
time since your cancer diagnosis” or “in the last month”,
it is unlikely that the longer period of retest would have
greatly affected the overall responses obtained. The
inclusion criteria also allowed items which had a low
weighted kappa value but a large proportion of partici-
p a n t s( >2 0 % )r e p o r t i n gah i g ho rv e r yh i g hl e v e lo f
need to remain in the measure, further ensuring that
important items were not excluded.
Although small, the overall sample included partici-
pants from five states and both large- and small-volume
treatment centres for AYA cancer patients. Therefore, it
is likely that a wide range of young people were
involved. Those who consented to take part in the study
were slightly younger and more likely to be female than
Table 3 Cronbach’s alpha for each Factor of the CNQ-YP




Factor 1 - Treatment Environment/
Care
33 0.98
Factor 2 - Daily Life 12 0.94
Factor 3 - Feelings/Relationships 14 0.92
Factor 4 - Information/Activities 5 0.83
Factor 5 - Education 3 0.82
Factor 6 - Work 3 0.89
Total Scale 70 0.98
Table 4 Comparison of factor scores between AYAs receiving treatment and AYAs finished treatment
Factor Receiving Treatment Finished Treatment Wilcoxon
rank sum
n median Q1 Q3 n median Q1 Q3 zp
1 - Treatment Environment/Care 17 1.8 1.1 2.1 116 1.5 1.2 2.2 0.32 0.75
2 - Daily Life 17 2.3 1.1 3.2 115 1.4 1.0 2.2 1.46 0.14
3 - Feelings/Relationships 17 2.4 1.6 2.6 115 1.5 1.2 2.3 1.81 0.07
4 - Information/Activities 17 3.6 1.6 3.8 116 2.2 1.5 2.8 1.58 0.11
5 - Education 11 1.3 1.0 2.0 67 1.7 1.0 2.7 -0.92 0.36
6 - Work 13 1.3 1.0 3.0 94 1.3 1.0 2.0 0.53 0.60
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Page 8 of 11those who did not consent. However, participation by
AYAs with a range of cancer types, at different stages
since their cancer diagnoses, increases the probability
that the items identified as important in the measure
represent the views of the larger AYA cancer
population.
Finally it should be noted that, apart from infertility,
issues surrounding other aspects of sexual health and
intimacy were not raised in focus group discussions or
in the pilot study. Such items were therefore not incor-
porated into the measure. The absence of these items
may reflect the young age of participants in the pilot
study compared to participants in the main trial. It is
recommended that issues surrounding sexual health are
further investigated in future scale development.
Psychometric strengths of the CNQ-YP
Despite the difficulties with recruitment, the current
study had a number of strengths related to the psycho-
metric development of the CNQ-YP and the measure
compared favourably with recognised psychometric cri-
teria. Reliability and validity of the CNQ-YP was exam-
ined using appropriate psychometric methods. The final
factor structure of the CNQ-YP showed that the four
main factors accounted for 63% of the variance. This
was considered acceptable, as the average variance
accounted for by exploratory factor analysis is around
60% [36]. This outcome also compares well with other
quality of life measures developed for AYA cancer survi-
vors, such as the Adolescent Quality of Life Instrument
(AQoL) which reported having six factors representing
67% of the variance [31], and the Quality of Life - Can-
cer Survivors (QOL-CS) instrument which also has six
factors accounting for 56% of the variance [32].
In addition, the CNQ-YP achieved high Cronbach’s
alphas, with all six factors reporting alphas greater than
0 . 8 0 .I ti sp o s s i b l et h a ts o m ea l p h av a l u e sm a yh a v e
been artificially high due to the large number of items
in the factors [25,38]. However, no items had correla-
tions < 0.20, and alphas > 0.80 were also reached in Fac-
t o r s5a n d6( W o r ka n dE d u c a t i o n ) ,b o t ho fw h i c hh a d
only three items. Although most of the available quality
of life measures developed for AYA cancer survivors
have at least some domains with alphas > 0.70, no scales
achieved alphas greater than 0.70 for all domains [16].
In the case of the Perceived Illness Experience Scale
(PIE), only two out of nine domains had alpha values >
0.70, showing variability in the internal consistency of
these measures [16].
A further strength of this study is that it assessed test-
retest reliability, unlike many other studies reporting the
development of measures for cancer patients and survi-
vors [16,39]. All but four items in the measure had
weighted kappa values > 0.60, and these four items all
had weighted kappas > 0.49. In comparison, a recent
review found that test-retest reliability was reported for
only one instrument measuring quality of life in AYA
cancer survivors [16]. However, for this measure ICCs
were only reported at the domain level rather than the
item level. This can be misleading as, although total
agreement levels for the domain may be high, agreement
for individual items may vary [40].
Recommended improvements for the CNQ-YP
In the current study, the CNQ-YP was unable to distin-
guish between AYAs currently receiving treatment and
those who had completed treatment. For Factors 1, 4, 5
and 6 (Treatment Environment and Care, Information
and Activities, Education, and Work) this may have
been because the response time-frame was “any time
since diagnosis”. Therefore, patients who had completed
treatment may have been reflecting a need level they
had while receiving treatment. The small sample size in
the receiving treatment group (n = 17) may have also
limited the power for hypothesis testing. There was a
non-significant trend toward AYAs receiving treatment
reporting higher needs related to Feelings and Relation-
ships. This could be further explored with a larger
sample.
The CNQ-YP did not appear to have a ceiling effect
(< 5.1% of participants scored the highest possible score
in each domain). However, there was a large floor effect
for all domains. This may have implications for inter-
vention studies where researchers wish to measure a
reduction in needs, as a large proportion of participants
(between 8.3% and 43%) are already scoring the
Table 5 Floor and ceiling effects per factor
Factor Lowest possible score Highest possible score
n n (%) n (%)
Factor 1 - Treatment Environment/Care 133 11 (8.3) 1 (0.8)
Factor 2 - Daily Life 132 36 (27) 0 (0.0)
Factor 3 - Feelings/Relationships 132 19 (14) 0 (0.0)
Factor 4 - Information/Activities 133 16 (12) 6 (4.5)
Factor 5 - Education 78 33 (42) 4 (5.1)
Factor 6 - Work 107 46 (43) 4 (3.7)
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Page 9 of 11minimum possible scores for each factor. However, fac-
tors with the largest floor effects (Education 42% and
Work 43%) were only completed by a sub-group of par-
ticipants. Therefore, a larger sample of AYAs may pro-
duce different results. These floor effects may also
indicate that the majority of young people do not
experience high levels of need in these areas. However,
the Education factor also had the highest ceiling effect
(5.1%), suggesting that this is probably not the case.
Testing of convergent and divergent validity, respon-
siveness and predictive validity was beyond the scope of
the present study. It is recommended that future psy-
chometric testing of the measure be undertaken to
explore these issues further. The small sample size
means that the factor structure achieved in the current
study may not be reproducible. Therefore, it is also
recommended that confirmatory factor analysis with a
larger sample of AYA cancer survivors be conducted
prior to using the measure in clinical practice [36,41].
Conclusions
The CNQ-YP is the first multi-dimensional measure of
unmet need which has been developed specifically for
AYA cancer patients and survivors. The measure dis-
plays a strong factor structure, and good internal consis-
tency and test-retest reliability. Future studies with a
larger sample size are recommended to determine the
discriminate validity and floor and ceiling effects of the
measure. Longitudinal studies to establish responsive-
ness and predictive validity should also be undertaken.
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